Improving Supply Chain Resilience: HPAPI Containment And Batch Reliability In Global Pharma Manufacturing
Global pharmaceutical supply chains are under sustained pressure from rising regulatory expectations, complex molecules, and frequent disruptions across geographies. For manufacturers handling highly potent active pharmaceutical ingredients (HPAPIs), the challenge is more pronounced.
Global Clinical Trials: How Strategic Partnerships and Emerging Markets Are Shaping the Future of Inclusive Research
Clinical trials sit at the heart of modern drug development. They are the bridge between promising science and real-world patient benefit. Yet the way trials are planned and executed has changed sharply in the last decade. Sponsors are dealing with complex biologics, precision medicines, combination therapies, and indications where standard endpoints are evolving.
Forging the Future: Why Strategic Outsourcing in Biologics is No Longer Optional, It’s Essential for Success
Publication: Fierce Biotechnology
Pharmacokinetics-focused bioanalysis for a half-life extended bispecific antibody in oncology
See how Syngene used MSD platform pharmacokinetics and immunogenicity assays to de-risk a half-life extended bispecific antibody in oncology. Explore the case study.
BIOSECURE Act 2025 update: what it means for biopharma outsourcing and what to do now
Publication: Pharmaceutical Technology Focus
Cell line development: faster path to a stable master cell bank
Cell line development is a critical early step in biologics manufacturing. For monoclonal antibodies and other therapeutic proteins, the quality of the master cell bank determines not only expression levels but also long-term process stability, regulatory confidence, and downstream scalability.
Redefining What’s Possible in Low-Temperature Chemistry
Read how Syngene delivers ultra‑low‑temperature chemistry down to –90 °C with precision, safety, and full GMP scalability. Explore how our cryogenic infrastructure and expertise in sensitive transformations help de‑risk development and open access to complex, otherwise inaccessible chemistries. Discover how advanced thermal control and integrated manufacturing accelerate your most challenging programs.
Partnering for Precision in Small Molecule Drug Substance Development & Manufacturing
Read how Syngene accelerates small‑molecule development with integrated discovery‑to‑commercial capabilities and globally compliant GMP facilities. Explore how advanced process chemistry, analytical depth, and seamless tech transfer de‑risk scale‑up and strengthen manufacturing reliability.
Engineering the Future of Chemistry- New Modalities in Action: Expanding the CRDMO Frontier
Discover how our next‑generation modalities—photochemistry, biocatalysis, electrochemistry, and flow—unlock cleaner pathways and overcome synthetic bottlenecks. Read how these technologies enable faster optimization, late‑stage functionalization, and scalable, sustainable chemistry. Explore how our integrated platforms accelerate innovation from early discovery to development.
Redefining Boundaries in Sustainable Metathesis Chemistry
Explore how Syngene advances Ring‑Closing Metathesis with sustainable, catalyst‑efficient processes that boost yields and minimize waste. Learn how our ethylene‑trapping and recycling strategies reduce environmental impact while strengthening process robustness. See how scalable, green metathesis solutions can elevate performance across your development and manufacturing workflows.